Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Apps

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant miceGeorge Poulogiannis, Rebecca E McIntyre, Maria Dimitriadi, et al.
Meat Science|August 24, 2024
Changing Australia's trading language has enhanced the implementation of objective carcase measurement technologiesG E Gardner, H B Calnan, S L Connaughton, et al.
Endocrine-Related Cancer|August 25, 2018
Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZParaskevi Xekouki, Emily J Lodge, Jakob Matschke, et al.
Ebiomedicine|June 23, 2016
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical ImplicationsGeorge D Cresswell, John R Apps, Tasnim Chagtai, et al.
Development (Cambridge, England)|May 17, 2017
MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngiomaScott Haston, Sara Pozzi, Gabriela Carreno, et al.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Neuro-Oncology|February 9, 2024
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysisEric W Prince, John R Apps, John Jeang, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant miceGeorge Poulogiannis, Rebecca E McIntyre, Maria Dimitriadi, et al.
Meat Science|August 24, 2024
Changing Australia's trading language has enhanced the implementation of objective carcase measurement technologiesG E Gardner, H B Calnan, S L Connaughton, et al.
Endocrine-Related Cancer|August 25, 2018
Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZParaskevi Xekouki, Emily J Lodge, Jakob Matschke, et al.
Ebiomedicine|June 23, 2016
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical ImplicationsGeorge D Cresswell, John R Apps, Tasnim Chagtai, et al.
Development (Cambridge, England)|May 17, 2017
MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngiomaScott Haston, Sara Pozzi, Gabriela Carreno, et al.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Neuro-Oncology|February 9, 2024
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysisEric W Prince, John R Apps, John Jeang, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 6